Back in February, the Acasti Pharma Inc (NASDAQ: ACST) stock had hit its peak, but since then the stock has been in the middle of a prolonged slump.
Since hitting its high, the stock has fallen by as low as 60% to date. A fall of such proportions can often prove to be a buying opportunity for new or existing investors. However, at the same time, it should be noted that experts believe that the stock could actually fall further before it can go on any kind of turnaround.
This assertion is primarily due to the very nature of biotech penny stocks. Most of those stocks are prone to make significant moves either way and hence, there might be some way to go before the trend is reversed in the Acasti stock. Last year, the stock went from 31 cents a share in March to 90 cents a share in June and it now remains to be seen if the stock can actually mount a recovery after falling further.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life